Concepedia

Camille Taillé

CT

Statistics

Publications

80

Citations

5.5K

H-Index

41

Active since

2001

Affiliations

Inserm(Current)

Université Paris Cité

Assistance Publique – Hôpitaux de Paris

Hôpital Bichat-Claude-Bernard

Centre National de la Recherche Scientifique

Camille Taillé is an author at Inserm specializing in medicine, asthma, and allergy.

ORCID

Top concepts

Publications per year

2001–2025

80

Publications

80

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

, , +10

Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study

Marc Humbert, Camille Taillé, Laurence Mala et al. · European Respiratory Journal · 2018 · 265 citations · Full text

Bilirubin decreases NOS2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats

Sophie Lanone, Sébastien Bloc, Roberta Foresti et al. · The FASEB Journal · 2005 · 258 citations

, , +20

Mitochondrial Respiratory Chain and NAD(P)H Oxidase Are Targets for theAntiproliferative Effect of Carbon Monoxide in Human Airway SmoothMuscle

Camille Taillé, Jamel El‐Benna, Sophie Lanone et al. · Journal of Biological Chemistry · 2005 · 244 citations · Full text

Eosinophilic and Noneosinophilic Asthma

Liam G. Heaney, Luis Pérez de Llano, Mona Al‐Ahmad et al. · CHEST Journal · 2021 · 243 citations · Full text

1–5 of 80